Results 11 to 20 of about 92,484 (303)

Characterization and measurement of human apolipoprotein A-II by radioimmunoassay

Journal of Lipid Research, 1980
The development of a radioimmunoassay for apolipoprotein A-II (apo A-II) is described. Initial studies revealed a lack of immunological identity between purified apo A-II used as the standard and serum or HDL. Extensive testing of different buffers, standards, antisera, tracers, utilization of a detergent, and heating of sera failed to resolve the ...
R B Goldberg, J B Karlin, D J Juhn, A M Scanu, C Edelstein, A H Rubenstein   +5 more
openaire   +4 more sources

Turbidimetric Assay of Apolipoprotein A-II [PDF]

Clinical Chemistry and Laboratory Medicine, 1985
A turbidimetric assay for the quantification of apolipoprotein A-II in serum is described. Its adaptation for the Cobas Bio Analyser (Hoffmann La Roche) is reported. Regression analysis of apolipoprotein A-II values measured by turbidimetry revealed a good measure of agreement with the data obtained by radial immunodiffusion (RID) (r = 0.90, y = 0.97x +
Schriewer, H., Emke, F., Assmann, G.
openaire   +3 more sources

Immunonephelometric Determination of the Apolipoprotein A-II [PDF]

Clinical Chemistry and Laboratory Medicine, 1989
A fully mechanized immunonephelometric method is described for the rapid and specific determination of apolipoprotein A-II in serum. The method utilizes commercially available sheep antiserum against human apolipoprotein A-II. Nephelometry was performed with the Behring Nephelometer Analyzer (BNA). A single determination can be performed in 12 minutes,
Hafner, G., Luley, C., Prellwitz, W.
openaire   +2 more sources

APO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus [PDF]

Diabetes & Metabolism Journal, 2016
BackgroundApolipoprotein A2 (APO A2) is the second most abundant structural apolipoprotein in high density lipoprotein. Several studies have examined the possible effect of APO A2 on atherosclerosis incidence.
Fariba Koohdani, Haleh Sadrzadeh-Yeganeh, Mahmoud Djalali, Mohammadreza Eshraghian, Elham Zamani, Gity Sotoudeh, Mohammad-Ali Mansournia, Laleh Keramat   +7 more
doaj   +1 more source

Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse

Journal of Lipid Research, 2003
Senescence-accelerated mouse-prone (SAMP1; SAMP1@Umz) is an animal model of senile amyloidosis with apolipoprotein A-II (apoA-II) amyloid fibril (AApoAII) deposits.
Makiko Umezawa, Kenjiro Tatematsu, Tatsumi Korenaga, Xiaoying Fu, Takatoshi Matushita, Harumi Okuyama, Masanori Hosokawa, Toshio Takeda, Keiichi Higuchi   +8 more
doaj   +1 more source

Amyloid fibrils formed by selective N-, C-terminal sequences of mouse apolipoprotein A-II [PDF]

, 2009
In mice, amyloidogenic type C apolipoprotein A-II (apoA-II) forms amyloid fibrils in age-associated amyloidosis. To understand the mechanism of amyloid fibril formation by apoA-II, we examined the polymerization of synthetic partial peptides of apoA-II ...
Tsutsumi-Yasuhara, Shinobu, Mori, Masayuki, Sawashita, Jinko, Higuchi, Keiichi, Yan, Jingmin, Naiki, Hironobu, Kametani, Fuyuki, Hasegawa, Kazuhiro, Zhang, Beiru   +8 more
core   +1 more source

Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins

Journal of Lipid Research, 2006
Plasma phospholipid transfer protein (PLTP) is a multifaceted protein with diverse biological functions. It has been shown to exist in both active and inactive forms.
Marian C. Cheung, John J. Albers
doaj   +1 more source

Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels [PDF]

, 2003
The impact of common variants in the apolipoprotein gene cluster (APOC3-A4-A5) on prospective coronary heart disease (CHD) risk was examined in healthy UK men. Of the 2808 men followed over 9 years, 187 had a clinically defined CHD event.
Hawe, E., Miller, G.J., Hawe, Emma, Nicaud, V., Wong, W.-M.R., Wong, Wai-man R., Humphries, S.E., Li, Lai K., Li, L.K., Talmud, P.J., Nicaud, Viviane, Miller, George J., Pennacchio, Len A., Talmud, Philippa J., Pennacchio, L.A., Humphries, Steve E.   +15 more
core   +1 more source

Apolipoprotein A-II [PDF]

Circulation Research, 2003
Familial combined hyperlipidemia (FCH) was originally identified as a new phenotype in studies of survivors of myocardial infarctions and their relatives.1–3 Patients with FCH were found to present with any of three patterns of lipoprotein distribution: elevated plasma levels of very low-density lipoprotein (VLDL) or low-density lipoprotein (LDL) or ...
Bradley E, Aouizerat, John P, Kane
openaire   +2 more sources

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II

Journal of Lipid Research, 2006
Endothelial lipase (EL) plays an important physiological role in modulating HDL metabolism. Data suggest that plasma contains an inhibitor of EL, and previous studies have suggested that apolipoprotein A-II (apoA-II) inhibits the activity of several ...
Uli C. Broedl, Weijun Jin, Ilia V. Fuki, John S. Millar, Daniel J. Rader   +4 more
doaj   +1 more source